AzTrials
AzTrials

PCLNCT02974205

Rehabilitation of Patient With Acute Isolated PCL Rupture

A study testing Jack brace, Rehabilitation and össur brace in people with PCL, run by Oslo University Hospital at 2 sites in Norway.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The posterior cruciate ligament injuries (PCL) is rare and rehabilitation methods are varying. The purpose of the study is to explore if one rehabilitation option is preferable to one other for patients with acute PCL injury, by examining whether there will be differences in laxity in the knee joints and… Read more about this study

Who is it for?
Ages 16 to 60 yearsHealthy volunteers can take part
Conditions the study is for
PCL
What is being tested?
Jack brace, Rehabilitation and össur brace
Could I receive a placebo?
No, everyone receives an active treatment
How many people
80 participants
Where
2 sitesNorway
Study dates
Jan 2016to Sep 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 16 to 60 years
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult

Who may be able to join

  • Acute isolated PCL injury : 0- 3 weeks ( maximum 21 days) from the initial injury
  • Isolated PCL rupture (grade I, II and III)
  • Patient age should be between 16-60 years ( with closed epiphyseal plate )
  • Understood and accepted written consent

Who cannot join

  • Injury to the ACL or other ligaments in the knee
  • Extensive injury to the cartilage or meniscus , requiring repairs
  • Unfit to understand or to sign consent
  • History of alcohol or drug abuse in the past three years
  • Current serious illness or injury that makes rehabilitation difficult.

Trial locations and contacts

2 sites in 1 country.

Ingrid Trøan, PT contact

+479888593

ingrid.troan@ous-hf.no

Karin Bredland, PT, MSc contact

Norway2 sites, 2 recruiting
  • Akershus University Hospital

    Lørenskog, 1478

    Hilde Stømner, PT, Hilde.Christina.Stomner@ahus.no

    Recruiting
  • Oslo University Hospital

    Oslo, 0182

    Ingrid Trøan, PT, 22117213, uxtrai@ous-hf.no

    Karin Bredland, PT, MSc, 22117213, uxkbar@ous-hf.no

    Recruiting

Other trials in Norway

About this study

Official title: Kneelaxity and Self-reported Knee Function After Rehabilitation With the Use of Dynamic Kneeorthosis for Patients With Acute Isolated Posterior Cruciate Ligament Injury: A Randomized Controlled Trial

The posterior cruciate ligament injuries (PCL) is rare and rehabilitation methods are varying. The purpose of the study is to explore if one rehabilitation option is preferable to one other for patients with acute PCL injury, by examining whether there will be differences in laxity in the knee joints and patient-reported knee function by three different rehabilitation protocols. A randomized controlled trial with 75 patients enrolled will be followed up 3 and 12 months after injury. The groups will be compared using kneelaxity (stress - X) and subjective knee function (KOOS, IKDC-2000)

Read the detailed description

The posterior cruciate ligament injuries (PCL) is rare and rehabilitation methods are varying. The purpose of the study is to explore if one rehabilitation option is preferable to one other for patients with acute PCL injury, by examining whether there will be differences in laxity in the knee joints and patient-reported knee function by three different rehabilitation protocols. A randomized controlled trial with 75 patients enrolled will be followed up 3 and 12 months after injury. The groups will be compared using kneelaxity (stress - X) and subjective knee function (KOOS, IKDC-2000) to indicate whether one rehabilitation alternative is preferable in terms of less knee joint laxity and improve knee function. Participants considered included in the study if he or she agrees to participate in the study by signing the informed consent. Inclusion criteria will be whether the patient has an acute isolated PCL injury. Exclusion is additional injuries of ligaments, cartilage and meniscus of the knee. Randomization to groups is done continuously.

Conditions
PCL
Being tested
Jack brace, Rehabilitation, össur brace

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Jack braceProcedure or surgery

    Rehabilitation after acute isolated PCL rupture with orthosis

  • RehabilitationDevice

    Rehabilitation after acute isolated PCL rupture without orthosis

  • össur braceDevice

    Rehabilitation after acute isolated PCL rupture

Study groups in NCT02974205
Study groupRoleWhat they receive
Rehabilitation with orthosis (Jack brace)Active comparatorNot described
Receives: Procedure: Jack brace
Rehabilitation without orthosisActive comparatorNot described
Receives: Device: Rehabilitation
Rehabilitation with orthosis (össur brace)Active comparatorNot described
Receives: Device: össur brace

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. PCL stress-radiograph

    Measured: 12 month

Secondary outcomes (3)
  1. KOOS (Knee Injury and Osteoarthritis Outcome score)

    Measured: 12 month

  2. IKDC-2000 (Subjective Knee Evaluation Form)

    Measured: 12 month

  3. One leg hop (in meters)

    Measured: 12 month

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Nov 2016 (estimated)
  2. Study startJan 2016
  3. Primary completionSep 2025 (estimated)
  4. Study completionSep 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
80 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02974205
Sponsor's protocol ID
579239
Status last verified
Nov 2016
First submitted
17 Nov 2016
Last updated
28 Nov 2016
Results posted
No
Data monitoring committee
Yes
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Jack brace, Rehabilitation and össur brace in people with PCL, run by Oslo University Hospital at 2 sites in Norway.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 28 Nov 2016. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Norway. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Ingrid Trøan, PT (+479888593, ingrid.troan@ous-hf.no), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

PCL stress-radiograph (time frame: 12 month). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Nov 2016.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in